These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 329322)

  • 1. A standard- (trifluoperazine) controlled clinical study with clomacran in newly admitted schizophrenic patients.
    Pecknold JC; Ban TA; Lehmann HE
    Psychopharmacol Bull; 1977 Jul; 13(3):14-5. PubMed ID: 329322
    [No Abstract]   [Full Text] [Related]  

  • 2. A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, I.
    Amin MM; Ban TA; Lehmann HE
    Psychopharmacol Bull; 1977 Jul; 13(3):15-7. PubMed ID: 329323
    [No Abstract]   [Full Text] [Related]  

  • 3. A standard- (trifluoperazine) controlled clinical study with pimozide in the maintenance treatment of schizophrenic patients, II.
    Vergara L; Amin MM; Ban TA
    Psychopharmacol Bull; 1977 Jul; 13(3):17-9. PubMed ID: 329324
    [No Abstract]   [Full Text] [Related]  

  • 4. An uncontrolled clinical study with clomacran in newly admitted schizophrenic patients.
    Torres-Ruiz A; Nieto D; Ban TA
    Psychopharmacol Bull; 1977 Jul; 13(3):6-7. PubMed ID: 329331
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind comparison of the acridane derivative, clomacran phosphate and trifluoperazine in schizophrenia.
    Angus JW; Deutsch LJ; Edwards JG; Simpson GM
    Behav Neuropsychiatry; 1969 Apr; 1(1):13-8. PubMed ID: 4920977
    [No Abstract]   [Full Text] [Related]  

  • 6. Centbutindole vs trifluoperazine: a double-blind controlled clinical study in acute schizophrenia.
    Doongaji DR; Satoskar RS; Sheth AS; Apte JS; Desai AB; Shah BR
    J Postgrad Med; 1989 Jan; 35(1):3-8. PubMed ID: 2685263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clomacran in the treatment of schizophrenic patients: a comparison of two assessment methods.
    Pecknold JC; Ban TA; Lehmann HE; Climan M
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):299-303. PubMed ID: 1099021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind study of SKF 14336 vs. trifluoperazine in schizophrenic patients.
    Freeman H; Oktem N; Oktem MR
    Curr Ther Res Clin Exp; 1968 Oct; 10(10):537-42. PubMed ID: 4971470
    [No Abstract]   [Full Text] [Related]  

  • 9. A twelve month comparison of penfluridol and trifluoperazine in chronic schizophrenic outpatients.
    Donlon PT; Meyer JE
    J Clin Psychiatry; 1978 Jun; 39(6):582-3, 686-8. PubMed ID: 350861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative short-term evaluation of penfluridol and trifluoperazine in chronic schizophrenia.
    Khorana AB; Patel Y
    Indian J Physiol Pharmacol; 1988; 32(4):293-8. PubMed ID: 3063660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia.
    Knight RG; Harrison A
    N Z Med J; 1979 Apr; 89(634):302-4. PubMed ID: 377155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiothixene versus trifluoperazine in newly-admitted schizophrenic patients.
    Bishop MP; Fulmer TE; Gallant DM
    Curr Ther Res Clin Exp; 1966 Nov; 8(11):509-14. PubMed ID: 4962777
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of schizophrenia with long-acting oral neuroleptics: a six-month double-blind investigation of penfluridol versus trifluoperazine.
    Abuzzahab FS
    Psychopharmacol Bull; 1977 Jul; 13(3):26-7. PubMed ID: 329326
    [No Abstract]   [Full Text] [Related]  

  • 14. Clomacran and chlorpromazine in psychotic outpatients: a controlled study.
    Case WG; Ryder BL; Dhopeshwarkar VP; Pereira-Ogan JA; Rickels K
    Curr Ther Res Clin Exp; 1971 Jun; 13(6):337-43. PubMed ID: 4996219
    [No Abstract]   [Full Text] [Related]  

  • 15. A double-blind comparison of once-a-day pimozide, trifluoperazine, and placebo in the maintenance care of chronic schizophrenic outpatients.
    Gross HS
    Curr Ther Res Clin Exp; 1974 Jul; 16(7):696-705. PubMed ID: 4210459
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind comparison of loxitane--loxapine succinate and trifluoperazine hydrochloride in chronic schizophrenic patients.
    Moyano CZ
    Dis Nerv Syst; 1975 Jun; 36(6):301-4. PubMed ID: 238810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind comparison of pimozide vs. trifluoperazine in schizophrenic outpatients.
    Claghorn JL
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):1005-9. PubMed ID: 4214658
    [No Abstract]   [Full Text] [Related]  

  • 18. Loxapine: a controlled evaluation in chronic schizophrenic patients.
    Bishop MP; Gallant DM
    Curr Ther Res Clin Exp; 1970 Sep; 12(9):594-7. PubMed ID: 4989690
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of an acridan derivative (Smith Kline and French 14336) and trifluoperazine in the treatment of chronic schizophrenia.
    Needham RF; Blignault WJ
    Med J Aust; 1969 Sep; 2(11):550-3. PubMed ID: 5823733
    [No Abstract]   [Full Text] [Related]  

  • 20. A double blind study of clomacran.
    Lampe WT
    Curr Ther Res Clin Exp; 1969 May; 11(5):300-6. PubMed ID: 4977403
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.